EMID1
EMI domain-containing protein 1
Also known as: EMI5, EMID1_HUMAN, EMU1, hEmu1
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q96A84
- Gene
- EMID1
- Ensembl
- ENSG00000186998
- Chromosome
- 22
- Canonical length
- 441 aa
- Protein class
- Predicted intracellular proteins, Predicted secreted proteins
- Secretome location
- Secreted in other tissues
OverviewNCBI Gene
Predicted to be located in several cellular components, including Golgi apparatus; endoplasmic reticulum; and extracellular matrix. Predicted to be part of collagen trimer. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
441 residues, UniProt reviewed canonical sequence.
>Q96A84|EMID1
1 MGGPRAWALL CLGLLLPGGG AAWSIGAAPF SGRRNWCSYV VTRTISCHVQ NGTYLQRVLQ
61 NCPWPMSCPG SSYRTVVRPT YKVMYKIVTA REWRCCPGHS GVSCEEASSA SLEPMWSGST
121 MRRMALRPTA FSGCLNCSKV SELTERLKVL EAKMTMLTVI EQPVPPTPAT PEDPAPLWGP
181 PPAQGSPGDG GLQDQVGAWG LPGPTGPKGD AGSRGPMGMR GPPGPQGPPG SPGRAGAVGT
241 PGERGPPGPP GPPGPPGPPA PVGPPHARIS QHGDPLLSNT FTETNNHWPQ GPTGPPGPPG
301 PMGPPGPPGP TGVPGSPGHI GPPGPTGPKG ISGHPGEKGE RGLRGEPGPQ GSAGQRGEPG
361 PKGDPGEKSH WGEGLHQLRE ALKILAERVL ILETMIGLYE PELGSGAGPA GTGTPSLLRG
421 KRGGHATNYR IVAPRSRDER GLocalizationUniProt · AlphaFold · HPA
Whether an antibody against EMID1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Secreted
- Secreted
- Yes
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.66
- Highest tissue expression
- 53 nTPM
Expression across tissuesHPA
Tissue
- spleen: 53 nTPM
- cerebral cortex: 37 nTPM
- amygdala: 34 nTPM
- adrenal gland: 31 nTPM
- basal ganglia: 25 nTPM
- hippocampal formation: 24 nTPM
Single-cell type
- megakaryocyte-erythroid progenitors: 165 nCPM
- astrocytes: 108 nCPM
- oligodendrocyte progenitor cells: 105 nCPM
- hematopoietic stem cells: 86 nCPM
- bergmann glia: 74 nCPM
- erythrocyte progenitors: 73 nCPM
Immune cell
- NK-cell: 0.4 nTPM
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
Brain region
- cerebral cortex: 29 nTPM
- hippocampal formation: 26 nTPM
- basal ganglia: 25 nTPM
- amygdala: 24 nTPM
- white matter: 20 nTPM
- midbrain: 16 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.98
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.51
- DepMap mean gene effect
- -0.08
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads EMID1 as an antibody target. Whether an autoantibody or antibody against EMID1 could matter depends on whether native EMID1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
EMID1 is annotated as secreted, so native EMID1 circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.
Annotation status
The present source text does not explicitly label EMID1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...